沈阳三生制药有限责任公司 SBIO INC.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010 2010-01-26 13:36
3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 2010-01-08 17:17
3SBio Inc. Announces Unaudited Third Quarter 2009 Results 2009-11-13 06:00
3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009 2009-10-28 01:04
3SBio Inc. Announces Results of Annual General Meeting 2009-10-20 11:37
3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009 2009-09-07 08:58
3SBio Inc. Announces Unaudited Second Quarter 2009 Results 2009-08-12 05:00
3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 2009-07-23 16:01
3SBio Inc. Announces Unaudited First Quarter 2009 Results 2009-05-20 05:00
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor 2009-05-05 19:30
3SBio Inc. to Report 2009 First Quarter Earnings on May 19, 2009 2009-05-04 19:30
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results 2009-03-12 05:00
3SBio Inc. Receives Official Recognition as a ‘High-Tech Enterprise’ 2009-03-05 21:30
3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009 2009-02-25 21:00
3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 2009-02-09 21:30
3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP 2009-01-20 21:30
3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference 2008-11-25 05:30
3SBio Inc. Announces Third Quarter 2008 Results 2008-11-11 05:30
3SBio Inc. Files for SFDA Approval of NuLeusin 2008-11-10 21:00
3SBio Inc. Announces Preliminary Third Quarter 2008 Results 2008-11-01 06:15
1 3 4 5 6 7